Efficacy and Safety Study of Z160 in Subjects With Postherpetic Neuralgia
Public ClinicalTrials.gov record NCT01757873. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Z160 in Subjects With Postherpetic Neuralgia
Study identification
- NCT ID
- NCT01757873
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Zalicus
- Industry
- Enrollment
- 144 participants
Conditions and interventions
Conditions
Interventions
- Z160 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2012
- Primary completion
- Oct 31, 2013
- Completion
- Oct 31, 2013
- Last update posted
- Dec 11, 2013
2012 – 2013
United States locations
- U.S. sites
- 53
- U.S. states
- 27
- U.S. cities
- 53
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigative Site | Birmingham | Alabama | 35216 | — |
| Investigative Site | Chandler | Arizona | 85224 | — |
| Investigative Site | Mesa | Arizona | 85213 | — |
| Investigative Site | Peoria | Arizona | 85381 | — |
| Investigative Site | Phoenix | Arizona | 85020 | — |
| Investigative Site | Scottsdale | Arizona | 85251 | — |
| Investigative Site | Little Rock | Arkansas | 72205 | — |
| Investigative Site | Irvine | California | 92618 | — |
| Investigative Site | Los Angeles | California | 90033 | — |
| Investigative Site | San Francisco | California | 94109 | — |
| Investigative Site | Thousand Oaks | California | 91360 | — |
| Investigative Site | Boulder | Colorado | 80304 | — |
| Investigative Site | Colorado Springs | Colorado | 80920 | — |
| Investigative Site | Denver | Colorado | 80218 | — |
| Investigative Site | Brooksville | Florida | 34601 | — |
| Investigative Site | Clearwater | Florida | 33756 | — |
| Investigative Site | Miami | Florida | 33015 | — |
| Investigative Site | Orlando | Florida | 32806 | — |
| Investigative Site | Port Orange | Florida | 32127 | — |
| Investigative Site | Royal Palm Beach | Florida | 33411 | — |
| Investigative Site | Sarasota | Florida | 34243 | — |
| Investigative Site | Tampa | Florida | 33606 | — |
| Investigative Site | Chicago | Illinois | 60602 | — |
| Investigative Site | Evansville | Indiana | 47714 | — |
| Investigative Site | Shreveport | Louisiana | 71105 | — |
| Investigative Site | Columbia | Maryland | 21045 | — |
| Investigative Site | Boston | Massachusetts | 02131 | — |
| Investigative Site | Ann Arbor | Michigan | 48104 | — |
| Investigative Site | Bay City | Michigan | 48706 | — |
| Investigative Site | Ocean Springs | Mississippi | 39564 | — |
| Investigative Site | Hazelwood | Missouri | 63031 | — |
| Investigative Site | Kansas City | Missouri | 64114 | — |
| Investigative Site | St Louis | Missouri | 63117 | — |
| Investigative Site | Omaha | Nebraska | 68124 | — |
| Investigative Site | Toms River | New Jersey | 08755 | — |
| Investigative Site | Albuquerque | New Mexico | 87102 | — |
| Investigative Site | Brooklyn | New York | 11235 | — |
| Investigative Site | New York | New York | 10016 | — |
| Investigative Site | Greensboro | North Carolina | 27410 | — |
| Investigative Site | Beavercreek | Ohio | 45432 | — |
| Investigative Site | Columbus | Ohio | 43214 | — |
| Investigative Site | Kettering | Ohio | 45429 | — |
| Investigative Site | Oklahoma City | Oklahoma | 73112 | — |
| Investigative Site | Charleston | South Carolina | 29407 | — |
| Investigative Site | Nashville | Tennessee | 37205 | — |
| Investigative Site | Tullahoma | Tennessee | 37388 | — |
| Investigative Site | Austin | Texas | 78731 | — |
| Investigative Site | Richardson | Texas | 75080 | — |
| Investigative Site | Murray | Utah | 84123 | — |
| Investigative Site | Salt Lake City | Utah | 84106 | — |
| Investigative Site | Herndon | Virginia | 20171 | — |
| Investigative Site | Bellevue | Washington | 98007 | — |
| Investigative Site | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01757873, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 11, 2013 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01757873 live on ClinicalTrials.gov.